Enrique Colado

2.9k total citations
35 papers, 683 citations indexed

About

Enrique Colado is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Enrique Colado has authored 35 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 14 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Enrique Colado's work include Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (5 papers). Enrique Colado is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (5 papers). Enrique Colado collaborates with scholars based in Spain, United Kingdom and United States. Enrique Colado's co-authors include Jesús F. San Miguel, Jesús Martín, Enrique M. Ocio, Patricia Maiso, Mercedes Garayoa, Atanasio Pandiella, María‐Belén Vídriales, José Ramón González‐Porras, Carlos López-Otı́n and Pilar Sánchez-Conde and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Enrique Colado

33 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrique Colado Spain 16 327 241 165 159 99 35 683
Shigeru Takamoto Japan 15 220 0.7× 181 0.8× 95 0.6× 115 0.7× 92 0.9× 46 668
Kazuyuki Shigeno Japan 15 296 0.9× 364 1.5× 45 0.3× 238 1.5× 70 0.7× 36 644
Haley E. Ramsey United States 17 335 1.0× 464 1.9× 149 0.9× 117 0.7× 79 0.8× 36 798
Paula J.M. Vossebeld Netherlands 14 216 0.7× 332 1.4× 277 1.7× 218 1.4× 47 0.5× 16 849
Antonio R. Lucena‐Araujo Brazil 16 223 0.7× 404 1.7× 77 0.5× 178 1.1× 152 1.5× 62 750
Francisco Vidal Spain 19 287 0.9× 440 1.8× 179 1.1× 68 0.4× 70 0.7× 60 985
Lisa Gallinaro Italy 16 396 1.2× 306 1.3× 113 0.7× 84 0.5× 84 0.8× 32 856
Amy M. Bertino United States 7 510 1.6× 246 1.0× 220 1.3× 61 0.4× 114 1.2× 11 903
Yuh‐Ching Twu Taiwan 18 269 0.8× 263 1.1× 175 1.1× 56 0.4× 83 0.8× 36 737
Hideaki Fujiwara Japan 17 214 0.7× 275 1.1× 286 1.7× 223 1.4× 75 0.8× 71 909

Countries citing papers authored by Enrique Colado

Since Specialization
Citations

This map shows the geographic impact of Enrique Colado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Colado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Colado more than expected).

Fields of papers citing papers by Enrique Colado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Colado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Colado. The network helps show where Enrique Colado may publish in the future.

Co-authorship network of co-authors of Enrique Colado

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Colado. A scholar is included among the top collaborators of Enrique Colado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Colado. Enrique Colado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Córdoba, Santiago Rodrı́guez de, et al.. (2025). C3 mutations and poor pegcetacoplan response in paroxysmal nocturnal hemoglobinuria. Frontiers in Immunology. 16. 1723596–1723596.
3.
Caballero‐Velázquez, Teresa, Eduardo Rodríguez‐Arbolí, Enrique Colado, et al.. (2023). Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study. Cancers. 15(5). 1609–1609. 8 indexed citations
4.
Alonso, Sara, Enrique Colado, Marco Antonio Moro‐García, & Rebeca Alonso‐Arias. (2021). Cytomegalovirus in Haematological Tumours. Frontiers in Immunology. 12. 703256–703256. 15 indexed citations
5.
Grille, Sofía, Marcelo Iastrebner, Irene Lorand‐Metze, et al.. (2019). Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world. Leukemia Research. 79. 69–74. 4 indexed citations
6.
Alonso, Sara, et al.. (2017). The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment. Annals of Hematology. 96(11). 1833–1840. 13 indexed citations
7.
Soria‐Valles, Clara, Ana Gutiérrez‐Fernández, Fernando G. Osorio, et al.. (2016). MMP-25 Metalloprotease Regulates Innate Immune Response through NF-κB Signaling. The Journal of Immunology. 197(1). 296–302. 39 indexed citations
8.
Villegas, Ana, Beatriz Arrizabalaga, Santiago Bonanad, et al.. (2016). Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 146(6). 278.e1–278.e7. 12 indexed citations
9.
Osorio, Fernando G., Clara Soria‐Valles, Olaya Santiago‐Fernández, et al.. (2015). Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling. Nature Medicine. 22(1). 91–96. 33 indexed citations
10.
Bernal, Teresa, Enrique Colado, Miguel Alcoceba, et al.. (2014). Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome. Leukemia Research. 38(5). 551–556. 15 indexed citations
11.
Rodríguez, Ramón María Alvargonzález, Beatriz Suárez-Álvarez, Manuel Muro, et al.. (2013). DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant. PLoS ONE. 8(2). e56931–e56931. 19 indexed citations
12.
Rubio, Montserrat López, Javier Loscertales, Enrique Colado, et al.. (2013). Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC). Leukemia & lymphoma. 55(5). 1007–1012. 16 indexed citations
13.
Rodríguez, Ramón María Alvargonzález, Beatriz Suárez-Álvarez, Manuel Muro, et al.. (2013). Correction: DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant. PLoS ONE. 8(9). 1 indexed citations
14.
González-López, Adrián, Alina Aguirre, Inés López-Alonso, et al.. (2012). MMP-8 Deficiency Increases TLR/RAGE Ligands S100A8 and S100A9 and Exacerbates Lung Inflammation during Endotoxemia. PLoS ONE. 7(6). e39940–e39940. 20 indexed citations
15.
Moncada-Pazos, Ángela, Álvaro J. Obaya, Maria Llamazares Prada, et al.. (2012). ADAMTS-12 Metalloprotease Is Necessary for Normal Inflammatory Response. Journal of Biological Chemistry. 287(47). 39554–39563. 39 indexed citations
16.
Crusoé, Edvan de Queiroz, Patricia Maiso, Diego Fernández‐Lázaro, et al.. (2011). Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma. Annals of Hematology. 91(2). 257–269. 4 indexed citations
17.
Urbano-Ispizúa, Álvaro, Anna Gayà, Enrique Colado, et al.. (2010). Diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 136(3). 121–127. 6 indexed citations
18.
Maiso, Patricia, Enrique Colado, Enrique M. Ocio, et al.. (2009). The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair. Leukemia. 23(12). 2265–2274. 57 indexed citations
19.
Mateos, María‐Victoria, et al.. (2007). Should prophylactic granulocyte‐colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide‐based therapy?. British Journal of Haematology. 140(3). 324–326. 12 indexed citations
20.
Colado, Enrique, Stela Álvarez-Fernández, Patricia Maiso, et al.. (2007). The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype. Haematologica. 93(1). 57–66. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026